Germany's reform law formally recognises the "chronically ill"
This article was originally published in Clinica
Executive Summary
The newly-appointed German federal committee of doctors, health insurance funds and patient representatives has finally published its regulations on which patients qualify to be classed as "chronically ill", and on the reimbursement of transport costs. The move appears to have dispelled confusion amongst the general public and brought somewhat unexpected praise from the committee's previous antagonist, health minister Ulla Schmidt (see Clinica No 1092, p 3).
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.